Jenburkt Pharmaceuticals Limited (BOM:524731)
India · Delayed Price · Currency is INR 1,042.30
-13.80 (-1.31%)
At close: Feb 12, 2026
Jenburkt Pharmaceuticals Market Cap
Jenburkt Pharmaceuticals has a market cap or net worth of 4.66 billion as of February 13, 2026. Its market cap has decreased by -8.96% in one year.
Market Cap
4.66B
Enterprise Value
4.59B
Revenue
1.65B
Ranking
n/a
PE Ratio
14.39
Stock Price
1,042.30
Market Cap Chart
Since November 21, 2001, Jenburkt Pharmaceuticals's market cap has increased from 33.01M to 4.66B, an increase of 14,030.30%. That is a compound annual growth rate of 22.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 4.66B | -3.02% |
| Dec 31, 2025 | 4.81B | -10.28% |
| Dec 31, 2024 | 5.36B | 78.59% |
| Dec 29, 2023 | 3.00B | 1.25% |
| Dec 30, 2022 | 2.96B | 21.19% |
| Dec 31, 2021 | 2.45B | 24.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accent Microcell | 6.93B |
| Kopran | 6.73B |
| Sudarshan Pharma Industries | 6.19B |
| Kilitch Drugs (India) | 5.90B |
| Medicamen Biotech | 4.46B |
| Everest Organics | 4.13B |
| Albert David | 4.04B |
| Medico Remedies | 4.01B |